Genome & Company (KOSDAQ:314130)
South Korea
· Delayed Price · Currency is KRW 6,350.00
-160.00 (-2.46%)
At close: Apr 28, 2026
126.38% (1Y)
| Market Cap | 221.57B |
| Revenue (ttm) | 24.59B |
| Net Income (ttm) | -6.43B |
| Shares Out | 34.89M |
| EPS (ttm) | -205.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 309,056 |
| Average Volume | 499,184 |
| Open | 6,510.00 |
| Previous Close | 6,510.00 |
| Day's Range | 6,220.00 - 6,510.00 |
| 52-Week Range | 2,440.00 - 10,180.00 |
| Beta | 0.56 |
| RSI | 39.87 |
| Earnings Date | Nov 14, 2025 |